Lise Lund Kjems - Sep 27, 2021 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
Chief Medical Officer
Signature
/s/ Lise Lund Kjems
Stock symbol
CYTH
Transactions as of
Sep 27, 2021
Transactions value $
$0
Form type
4
Date filed
9/28/2021, 09:47 AM
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTH Common Stock Award $0 +17.1K $0.00 17.1K Sep 27, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTH Stock Option (Right to buy) Award $0 +23.8K $0.00 23.8K Sep 27, 2021 Common Stock 23.8K $7.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests immediately with respect to one-quarter of the shares of common stock subject to the option, and vests with respect to the remaining shares over a four-year period in 48 equal monthly installments on the first day of each month following the date of grant.